UR9 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Clinuvel Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 5.41 EUR 0.19% Market Closed

Market Cap: €267.3m

	Clinuvel Pharmaceuticals Ltd F:UR9	AU
	Absa Group Ltd F:AU6	ZA
E	Endesa SA DUS:ENA	ES
A	Allianz SE XMUN:ALV	DE
C	Cemex SAB de CV F:CEXA	MX
	Exel Composites Oyj F:8TY	FI
I	IONOS Group SE F:IOS	DE
	DENTSPLY SIRONA Inc F:DY2	US
	Arizona Lithium Ltd F:UDE0	AU
F	Fujifilm Holdings Corp F:FJI	JP
G	Golden Ocean Group Ltd F:KT31	BM
	Varia US Properties AG SIX:VARN	CH
	China Shenhua Energy Co Ltd F:IKF	CN
	Douyu International Holdings Ltd F:DY8	CN
L	Lloyds Banking Group PLC F:LLD	UK
D	Deutsche Bank AG XMUN:DBK	DE
I	IVU Traffic Technologies AG XMUN:IVU	DE
	Nanobiotix SA F:5NR	FR

Profitability Summary

Clinuvel Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

97%

Declining Gross Margin

102% > 95%

Exceptional Operating Margin

45%

Strong 3Y Average Operating Margin

53%

Declining Operating Margin

60% > 45%

Exceptional Net Margin

34%

Strong 3Y Average Net Margin

38%

Declining Net Margin

37% > 34%

Exceptional Free Cash Flow Margin

42%

Strong 3Y Average Free Cash Flow Margin

39%

Declining Free Cash Flow Margin

59% > 42%

Positive ROE

14%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

110%

Declining ROIC

200% > 108%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.